News
09-16-2013, 10:50 PM
Australian researchers have identified a potentially treatable subtype of pancreatic cancer, which accounts for about 2% of new cases. This subtype expresses high levels of the HER2 gene. HER2-amplified breast and gastric cancers are currently treated with Herceptin.
More... (http://www.news-medical.net/news/20130917/Researchers-identify-potentially-treatable-subtype-of-pancreatic-cancer.aspx)
More... (http://www.news-medical.net/news/20130917/Researchers-identify-potentially-treatable-subtype-of-pancreatic-cancer.aspx)